Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
about
Results from Polish Spondyloarthritis Initiative registry (PolSPI) - methodology and data from - the first year of observationCirculating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFαHigh level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.Serum Heme Oxygenase-1 and BMP-7 Are Potential Biomarkers for Bone Metabolism in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.
P2860
Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Effect of tumour necrosis fact ...... ts with high disease activity.
@en
Effect of tumour necrosis fact ...... ts with high disease activity.
@nl
type
label
Effect of tumour necrosis fact ...... ts with high disease activity.
@en
Effect of tumour necrosis fact ...... ts with high disease activity.
@nl
prefLabel
Effect of tumour necrosis fact ...... ts with high disease activity.
@en
Effect of tumour necrosis fact ...... ts with high disease activity.
@nl
P2093
P2860
P50
P1476
Effect of tumour necrosis fact ...... nts with high disease activity
@en
P2093
K Pawlak-Buś
P Leszczyński
P2860
P356
10.3109/03009742.2013.805241
P577
2013-09-08T00:00:00Z